Posted on May 27, 2015

Late pregnancy bleeding, which remains one of the leading causes of maternal death worldwide, was the subject of a Multi-Departmental Grand Round held by Hamad Medical Corporation (HMC) as part of its continuing medical education programs.

The grand round provided a venue for doctors to discuss their experience as well as the latest scientific evidence in managing high-risk patients. Peripartum hemorrhage is severe bleeding that commonly occurs during the third trimester of pregnancy and near the time of delivery. Women can be at risk for peripartum hemorrhage if they have a personal or family history of bleeding disorder, an increased personal bleeding tendency, or if they are taking medications such as antiplatelet agents or anticoagulants.

“Main causes of peripartum hemorrhage can include uterine atony (a loss of tone in the uterine musculature), placental disorders, birth trauma injuries and coagulation disorders. The main symptom is severe bleeding which can occur unexpectedly,” explained Dr Arabo Ibrahim Bayo, Senior Consultant of Obstetric/Gynecology and the Lead of the labor room at HMC’s Women’s Hospital.

Dr. Bayo added that: “The risk of peripartum bleeding highlights the importance of seeking professional antenatal care in ensuring that any health risks are detected early on and managed appropriately throughout the woman’s pregnancy and labor, and after delivery. It allows physicians to make preparations on the management and intervention plan with how to deal with the bleeding when it occurs. Evidence has shown that recognizing the risk factors as well as timely and appropriate treatment are key to improving outcomes for both mother and child.”

The grand round is a joint initiative of the Medical Administration and Medical Education Departments under the leadership of Professor Michael Richmond, Chief Medical Officer, and Dr. Abdullatif Al Khal, HMC’s Deputy Chief Medical Officer and Director of the Department of Medical Education.

“Our commitment to providing evidence-based medical care is central to HMC’s goal of becoming an academic health system. As we work towards this goal, we are implementing a suite of internationally-recognized continuing medical education and continuing professional development programs, including the multi-departmental grand rounds, which are aimed at ensuring high standards of educational activities across all medical specialties,” said Dr. Al Khal.

“HMC has put various initiatives in place to ensure that the care we provide to patients is always grounded on the best available research. One of these initiatives is the multi-departmental grand round which is a platform for our multidisciplinary teams to talk about their experience in a case-based format,” said Dr. Reham Negmeldin, HMC’s Healthcare Improvement Program Manager, who organized the event with Dr. David John Vaughan, Executive Director of Quality and Patient Safety at HMC.

The grand round was moderated by Professor Abraham Marcus, HMC’s Chairman of Anesthesiology, Intensive Care Unit and Perioperative Medicine; Dr. Zeyd Merenkoy, Head of HMC’s Blood Bank; and Dr. Mohammad Shahata, Senior Consultant of Obstetrics and Gynecology at HMC’s Women’s Hospital. In addition to a faculty composed of HMC physicians and surgeons, the grand round also hosted Professor Marcus Lance from the Department of Anesthesiology at Maastricht University Medical Center in the Netherlands. Prof. Lance is a leading international figure with several publications on transfusion medicine.